Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy

J Investig Allergol Clin Immunol. 2013;23(1):52-3.

Authors

S Yoshida¹, Y Sakurai, T Takeda, K Fukuda

Affiliation

¹ Department of Pediatrics, Nara Prefectural Nara Hospital, Nara, Japan.

PMID: 23653975

No abstract available

Publication types

Case Reports

MeSH terms

B-Cell Activating Factor / blood*
Blood Coagulation
Child, Preschool
Female
Humans
Immunoglobulin G / blood
Immunoglobulins, Intravenous / administration & dosage
Immunoglobulins, Intravenous / therapeutic use*
Leukocyte Count
Mucocutaneous Lymph Node Syndrome / blood*
Mucocutaneous Lymph Node Syndrome / diagnosis
Mucocutaneous Lymph Node Syndrome / therapy*
Treatment Outcome
Tumor Necrosis Factor Ligand Superfamily Member 13 / blood*

Substances

B-Cell Activating Factor
Immunoglobulin G
Immunoglobulins, Intravenous
TNFSF13B protein, human
Tumor Necrosis Factor Ligand Superfamily Member 13